Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-020761)

Filing Details

Accession Number:: 0001209191-18-020761
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-19 20:15:38
Reporting Period:: 2018-03-15

Accepted Time:: 2018-03-19 20:15:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
920465	La Jolla Pharmaceutical Co	LJPC	Biological Products, (No Disgnostic Substances) (2836)	330361285

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1178579	C Kevin Tang	4747 Executive Drive, Suite 510 San Diego CA 92121		Yes	No	Yes	No
1191935	Tang Capital Partners Lp	4747 Executive Drive, Suite 510 San Diego CA 92121		No	No	Yes	No
1232621	Tang Capital Management Llc	4747 Executive Drive, Suite 510 San Diego CA 92121		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-15	508,474	$29.50	4,138,893	No	4	P	Indirect	By LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By LP

Footnotes

The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP.